Publication | Closed Access

Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes

OncologyMedicineCancer ManagementDiabetesPathologyBronchial NeoplasmSynergistic EffectsCancer TreatmentPharmacologyRadiation OncologyLung Cancer